{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:02:09Z","timestamp":1791478929830,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:00:00Z","timestamp":1720310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:00:00Z","timestamp":1720310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00428-024-03855-z","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T23:01:17Z","timestamp":1720306877000},"page":"471-478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Renal epithelioid angiomyolipomas overexpress TFE3 and the TFE3-regulated gene TRIM63 in the absence of TFE3 rearrangement"],"prefix":"10.1007","volume":"485","author":[{"given":"Katrina","family":"Collins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Bridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Mannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan C.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara L.","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad T.","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Ulbright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0164-5911","authenticated-orcid":false,"given":"Andres M.","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,7]]},"reference":[{"key":"3855_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/PAS.0b013e3181d90370","volume":"34","author":"F Brimo","year":"2010","unstructured":"Brimo F, Robinson B, Guo C et al (2010) Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am J Surg Pathol 34:715\u2013722","journal-title":"Am J Surg Pathol"},{"key":"3855_CR2","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/modpathol.2009.58","volume":"22","author":"G Martignoni","year":"2009","unstructured":"Martignoni G, Pea M, Gobbo S et al (2009) Cathepsin-K immunoreactivity distinguishes MiTF\/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol 22:1016\u20131022","journal-title":"Mod Pathol"},{"key":"3855_CR3","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/modpathol.2011.93","volume":"24","author":"G Martignoni","year":"2011","unstructured":"Martignoni G, Gobbo S, Camparo P et al (2011) Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions. Mod Pathol 24:1313\u20131319","journal-title":"Mod Pathol"},{"key":"3855_CR4","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1097\/PAS.0000000000001894","volume":"46","author":"P Argani","year":"2022","unstructured":"Argani P, Wobker SE, Gross JM et al (2022) PEComa-like neoplasms characterized by ASPSCR1-TFE3 fusion: another face of TFE3-related mesenchymal neoplasia. Am J Surg Pathol 46:1153\u20131159","journal-title":"Am J Surg Pathol"},{"key":"3855_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/PAS.0000000000000349","volume":"39","author":"JK Schoolmeester","year":"2015","unstructured":"Schoolmeester JK, Dao LN, Sukov WR et al (2015) TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis. Am J Surg Pathol 39:394\u2013404","journal-title":"Am J Surg Pathol"},{"key":"3855_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00428-014-1655-x","volume":"465","author":"Q Shen","year":"2014","unstructured":"Shen Q, Rao Q, Xia QY et al (2014) Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features. Virchows Arch 465:607\u2013613","journal-title":"Virchows Arch"},{"key":"3855_CR7","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/s41379-021-00803-z","volume":"34","author":"XM Wang","year":"2021","unstructured":"Wang XM, Zhang Y, Mannan R et al (2021) TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma. Mod Pathol 34:1596\u20131607","journal-title":"Mod Pathol"},{"key":"3855_CR8","unstructured":"Hes O, Raspollini MR, Martignoni G, Calio, A (2022) Epithelioid angiomyolipoma\/epithelioid PEComa of the kidney. In: Amin MB, Berney DM, Comperat EM, Menon S, Netto GJ Raspollini MR, Rubin MA Tickoo SK, Trujalic S (eds) WHO Classification of Tumours: Urinary and Male Genital Tumours,5th edn. Lyon (France): International Agency for Research on Cancer, pp 102\u2013104"},{"key":"3855_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/path.5875","volume":"257","author":"DC Salles","year":"2022","unstructured":"Salles DC, Asrani K, Woo J et al (2022) GPNMB expression identifies TSC1\/2\/mTOR-associated and MiT family translocation-driven renal neoplasms. J Pathol 257:158\u2013171","journal-title":"J Pathol"},{"key":"3855_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/PAS.0000000000000778","volume":"41","author":"SM McGregor","year":"2017","unstructured":"McGregor SM, Alikhan MB, John RA et al (2017) Melanotic PEComa of the sinonasal mucosa with NONO-TFE3 fusion: an elusive mimic of sinonasal melanoma. Am J Surg Pathol 41:717\u2013722","journal-title":"Am J Surg Pathol"},{"key":"3855_CR11","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1097\/PAS.0000000000001150","volume":"42","author":"L Wang","year":"2018","unstructured":"Wang L, Zhang Y, Chen YB et al (2018) VSTM2A overexpression is a sensitive and specific biomarker for mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney. Am J Surg Pathol 42:1571\u20131584","journal-title":"Am J Surg Pathol"},{"key":"3855_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.eururo.2020.03.003","volume":"78","author":"SL Skala","year":"2020","unstructured":"Skala SL, Wang X, Zhang Y et al (2020) Next-generation RNA sequencing-based biomarker characterization of chromophobe renal cell carcinoma and related oncocytic neoplasms. Eur Urol 78:63\u201374","journal-title":"Eur Urol"},{"key":"3855_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/gcc.22690","volume":"58","author":"BC Dickson","year":"2019","unstructured":"Dickson BC, Swanson D (2019) Targeted RNA sequencing: a routine ancillary technique in the diagnosis of bone and soft tissue neoplasms. Genes Chromosomes Cancer 58:75\u201387","journal-title":"Genes Chromosomes Cancer"},{"key":"3855_CR14","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv1234","volume":"44","author":"S Liu","year":"2016","unstructured":"Liu S, Tsai WH, Ding Y et al (2016) Comprehensive evaluation of fusion transcript detection algorithms and a meta-caller to combine top performing methods in paired-end RNA-seq data. Nucleic Acids Res 44:e47","journal-title":"Nucleic Acids Res"},{"key":"3855_CR15","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/bioinformatics\/btv710","volume":"32","author":"X Chen","year":"2016","unstructured":"Chen X, Schulz-Trieglaff O, Shaw R et al (2016) Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics 32:1220\u20131222","journal-title":"Bioinformatics"},{"key":"3855_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/PAS.0b013e31817ed7a6","volume":"33","author":"H Aydin","year":"2009","unstructured":"Aydin H, Magi-Galluzzi C, Lane BR et al (2009) Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association. Am J Surg Pathol 33:289\u2013297","journal-title":"Am J Surg Pathol"},{"key":"3855_CR17","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.juro.2008.05.041","volume":"180","author":"BR Lane","year":"2008","unstructured":"Lane BR, Aydin H, Danforth TL et al (2008) Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol 180:836\u2013843","journal-title":"J Urol"},{"key":"3855_CR18","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s00261-014-0083-3","volume":"39","author":"M Jinzaki","year":"2014","unstructured":"Jinzaki M, Silverman SG, Akita H et al (2014) Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging 39:588\u2013604","journal-title":"Abdom Imaging"},{"key":"3855_CR19","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","volume":"70","author":"SK Rakowski","year":"2006","unstructured":"Rakowski SK, Winterkorn EB, Paul E et al (2006) Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int 70:1777\u20131782","journal-title":"Kidney Int"},{"key":"3855_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0022-5347(01)63072-6","volume":"160","author":"DH Ewalt","year":"1998","unstructured":"Ewalt DH, Sheffield E, Sparagana SP et al (1998) Renal lesion growth in children with tuberous sclerosis complex. J Urol 160:141\u2013145","journal-title":"J Urol"},{"key":"3855_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/ndt\/gfy063","volume":"34","author":"JC Kingswood","year":"2019","unstructured":"Kingswood JC, Belousova E, Benedik MP et al (2019) Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness. Nephrol Dial Transplant 34:502\u2013508","journal-title":"Nephrol Dial Transplant"},{"key":"3855_CR22","doi-asserted-by":"publisher","first-page":"14337","DOI":"10.1038\/s41598-019-49814-6","volume":"9","author":"J Ni","year":"2019","unstructured":"Ni J, Yan F, Qin W et al (2019) Mutational analysis of renal angiomyolipoma associated with tuberous sclerosis complex and the outcome of short-term everolimus therapy. Sci Rep 9:14337","journal-title":"Sci Rep"},{"key":"3855_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ekir.2017.07.016","volume":"3","author":"O Pleniceanu","year":"2018","unstructured":"Pleniceanu O, Omer D, Azaria E et al (2018) mTORC1 inhibition is an effective treatment for sporadic renal angiomyolipoma. Kidney Int Rep 3:155\u2013159","journal-title":"Kidney Int Rep"},{"key":"3855_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12894-015-0118-2","volume":"15","author":"T Kuusk","year":"2015","unstructured":"Kuusk T, Biancari F, Lane B et al (2015) Treatment of renal angiomyolipoma: pooled analysis of individual patient data. BMC Urol 15:123","journal-title":"BMC Urol"},{"key":"3855_CR25","doi-asserted-by":"publisher","first-page":"e23379","DOI":"10.1371\/journal.pone.0023379","volume":"6","author":"SL Dabora","year":"2011","unstructured":"Dabora SL, Franz DN, Ashwal S et al (2011) Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease. PLoS ONE 6:e23379","journal-title":"PLoS ONE"},{"key":"3855_CR26","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","volume":"17","author":"DM Davies","year":"2011","unstructured":"Davies DM, de Vries PJ, Johnson SR et al (2011) Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin Cancer Res 17:4071\u20134081","journal-title":"Clin Cancer Res"},{"key":"3855_CR27","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/S0022-5347(17)37057-X","volume":"148","author":"C Tallarigo","year":"1992","unstructured":"Tallarigo C, Baldassarre R, Bianchi G et al (1992) Diagnostic and therapeutic problems in multicentric renal angiomyolipoma. J Urol 148:1880\u20131884","journal-title":"J Urol"},{"key":"3855_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/PAS.0b013e318206f2a9","volume":"35","author":"N Nese","year":"2011","unstructured":"Nese N, Martignoni G, Fletcher CD et al (2011) Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification. Am J Surg Pathol 35:161\u2013176","journal-title":"Am J Surg Pathol"},{"key":"3855_CR29","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/modpathol.2013.72","volume":"26","author":"W He","year":"2013","unstructured":"He W, Cheville JC, Sadow PM et al (2013) Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors. Mod Pathol 26:1355\u20131364","journal-title":"Mod Pathol"},{"key":"3855_CR30","doi-asserted-by":"publisher","first-page":"151538","DOI":"10.1016\/j.anndiagpath.2020.151538","volume":"47","author":"O Boudaouara","year":"2020","unstructured":"Boudaouara O, Kallel R, Dhieb D et al (2020) Renal angiomyolipoma: clinico-pathologic study of 17 cases with emphasis on the epithelioid histology and p53 gene abnormalities. Ann Diagn Pathol 47:151538","journal-title":"Ann Diagn Pathol"},{"key":"3855_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.urolonc.2021.09.010","volume":"40","author":"R Saoud","year":"2022","unstructured":"Saoud R, Kristof TW, Judge C et al (2022) Clinical and pathological features of renal epithelioid angiomyolipoma (PEComa): a single institution series. Urol Oncol 40:18\u201324","journal-title":"Urol Oncol"},{"key":"3855_CR32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2559.2009.03420.x","volume":"55","author":"H Faraji","year":"2009","unstructured":"Faraji H, Nguyen BN, Mai KT (2009) Renal epithelioid angiomyolipoma: a study of six cases and a meta-analytic study. Development of criteria for screening the entity with prognostic significance. Histopathology 55:525\u2013534","journal-title":"Histopathology"},{"key":"3855_CR33","doi-asserted-by":"publisher","first-page":"e692","DOI":"10.1016\/j.clgc.2020.04.004","volume":"18","author":"M Vannucchi","year":"2020","unstructured":"Vannucchi M, Minervini A, Salvi M et al (2020) TFE3 gene rearrangement in perivascular epithelioid cell neoplasm (PEComa) of the genitourinary tract. Clin Genitourin Cancer 18:e692\u2013e697","journal-title":"Clin Genitourin Cancer"},{"key":"3855_CR34","doi-asserted-by":"publisher","first-page":"550506","DOI":"10.3389\/fphys.2020.550506","volume":"11","author":"C Pablo Tortola","year":"2020","unstructured":"Pablo Tortola C, Fielitz B, Li Y et al (2020) Activation of tripartite motif containing 63 expression by transcription factor EB and transcription factor binding to immunoglobulin heavy chain enhancer 3 is regulated by protein kinase D and Class IIa histone deacetylases. Front Physiol 11:550506","journal-title":"Front Physiol"},{"key":"3855_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.humpath.2016.11.003","volume":"61","author":"N Jimbo","year":"2017","unstructured":"Jimbo N, Nishigami T, Noguchi M et al (2017) Hepatic angiomyolipomas may overexpress TFE3, but have no relevant genetic alterations. Hum Pathol 61:41\u201348","journal-title":"Hum Pathol"},{"key":"3855_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.humpath.2019.02.008","volume":"87","author":"RF Sharain","year":"2019","unstructured":"Sharain RF, Gown AM, Greipp PT et al (2019) Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study. Hum Pathol 87:65\u201374","journal-title":"Hum Pathol"},{"key":"3855_CR37","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.1172\/JCI128287","volume":"129","author":"K Asrani","year":"2019","unstructured":"Asrani K, Murali S, Lam B et al (2019) mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT\/TFE regulation. J Clin Invest 129:5584\u20135599","journal-title":"J Clin Invest"},{"key":"3855_CR38","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.3892\/or.2015.4254","volume":"34","author":"H Kawano","year":"2015","unstructured":"Kawano H, Ito Y, Kanai F et al (2015) Aberrant differentiation of Tsc2-deficient teratomas associated with activation of the mTORC1-TFE3 pathway. Oncol Rep 34:2251\u20132258","journal-title":"Oncol Rep"},{"key":"3855_CR39","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1038\/emboj.2011.257","volume":"30","author":"S Pena-Llopis","year":"2011","unstructured":"Pena-Llopis S, Vega-Rubin-de-Celis S, Schwartz JC et al (2011) Regulation of TFEB and V-ATPases by mTORC1. EMBO J 30:3242\u20133258","journal-title":"EMBO J"},{"key":"3855_CR40","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2013.03.012","volume":"153","author":"J Betschinger","year":"2013","unstructured":"Betschinger J, Nichols J, Dietmann S et al (2013) Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3. Cell 153:335\u2013347","journal-title":"Cell"},{"key":"3855_CR41","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","volume":"34","author":"P Argani","year":"2010","unstructured":"Argani P, Aulmann S, Illei PB et al (2010) A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol 34:1395\u20131406","journal-title":"Am J Surg Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03855-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-024-03855-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03855-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T09:03:58Z","timestamp":1726823038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-024-03855-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,7]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["3855"],"URL":"https:\/\/doi.org\/10.1007\/s00428-024-03855-z","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,7]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}